Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Blog
Dec 2, 2021
| Monét Stanford
How Inflation Penalties for Generic Medicines Could Worsen Drug Shortages
Blog
Nov 30, 2021
| Erica Klinger
2021 Report
Blog
Nov 29, 2021
| Erica Klinger
Process & Progress: A Recap of GRx+Biosims 2021
Blog
Nov 20, 2021
| Dan Leonard
AAM All Access Podcast: Lachman Consultants’ Robert Pollock
Press Release
Nov 19, 2021
| Rachel Schwartz
Association for Accessible Medicines Warns Build Back Better Act Threatens Patient Access
Blog
Nov 15, 2021
| Craig Burton
Inflation Rebate Proposal Builds on Bad Policy for Generics
Press Release
Nov 12, 2021
| Rachel Schwartz
AAM Statement on the Nomination of Dr. Robert Califf to Lead FDA
Blog
Nov 12, 2021
| Monét Stanford
Medicare Negotiations Serve as a Catalyst to a Perpetual Monopoly
Press Release
Nov 10, 2021
| Rachel Schwartz
Paula Witt Joins AAM as Senior Manager, State Government Affairs
Press Release
Nov 2, 2021
| Rachel Schwartz
AAM Opposes Latest Prescription Drug Reform Framework
Press Release
Oct 31, 2021
| Rachel Schwartz
Biosimilars Council Encourages Stakeholders, Advocates to Join #GlobalBiosimilarsWeek
Blog
Oct 27, 2021
| Dan Leonard
AAM All Access Podcast: Celebrating Pharmacists
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action